a new management approach to withdrawal has been evaluated , which uses a combination of alpha 1-blockade ( prazosin ) and cardioselective beta-blockade ( atenolol ) together with a benzodiazepine ( chlordiazepoxide ) .
C0005064
benzodiazepine
C0008188
chlordiazepoxide